Related Experiment Video
Updated: Sep 20, 2026

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
Published on: August 2, 2018
Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside
Cornel Badorff1, Kirk U Knowlton
1Department of Medicine, University of California, San Diego, USA. badorff@em.uni-frankfurt.de
Insights
Enteroviruses disrupt the dystrophin-glycoprotein complex (DGC) in the heart, causing dilated cardiomyopathy. This study shows coxsackievirus B2 protease cleaves dystrophin in patients, contributing to heart muscle disease.
Area of Science:
- Cardiology
- Virology
- Molecular Biology
Background:
- Genetic defects in the dystrophin-glycoprotein complex (DGC) are linked to hereditary dilated cardiomyopathy.
- Enteroviruses are known to cause cardiomyopathy, with a previously identified mechanism involving the viral protease 2A cleaving dystrophin.
Purpose of the Study:
- To investigate the role of dystrophin cleavage by enteroviruses in human dilated cardiomyopathy.
- To extend previous findings from mouse models to a clinical case of coxsackievirus B2 myocarditis.
Main Methods:
- Analysis of endomyocardial biopsy specimens from a patient with coxsackievirus B2 myocarditis.
- Immunostaining for enteroviral capsid antigen VP1 and DGC components (dystrophin, beta-sarcoglycan).
- In vitro experiments using coxsackievirus B2 protease 2A and human dystrophin.
Main Results:
- Patient biopsy showed inflammatory infiltrate, myocytolysis, and virus-infected cardiomyocytes.
- Loss of sarcolemmal staining for dystrophin and beta-sarcoglycan was observed in infected cardiomyocytes.
- Coxsackievirus B2 protease 2A was confirmed to cleave human dystrophin in vitro.
Conclusions:
- Focal disruption of the DGC occurs in human coxsackievirus B myocarditis.
- Enteroviral protease-mediated dystrophin cleavage may contribute to the pathogenesis of enterovirus-induced dilated cardiomyopathy.
Abstract:
Genetic defects of the dystrophin-glycoprotein complex (DGC) cause hereditary dilated cardiomyopathy. Enteroviruses can also cause cardiomyopathy and we have previously described a mechanism involved in enterovirus-induced dilated cardiomyopathy: The enteroviral protease 2A directly cleaves dystrophin in the hinge 3 region, leading to functional dystrophin impairment. During infection of mice with coxsackievirus B3, the DGC in the heart is disrupted and the sarcolemmal integrity is lost in virus-infected cardiomyocytes. Additionally, dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy in vivo, suggesting a pathogenetic role of the dystrophin cleavage in enterovirus-induced cardiomyopathy. Here, we extend these experimental findings to a patient with dilated cardiomyopathy due to a coxsackievirus B2 myocarditis. Endomyocardial biopsy specimens showed an inflammatory infiltrate and myocytolysis. Immunostaining for the enteroviral capsid antigen VP1 revealed virus-infected cardiomyocytes. Focal areas of cardiomyocytes displayed a loss of the sarcolemmal staining pattern for dystrophin and beta-sarcoglycan identical to previous findings in virus-infected mouse hearts. In vitro, coxsackievirus B2 protease 2A cleaved human dystrophin. These findings demonstrate that in human coxsackievirus B myocarditis a focal disruption of the DGC can principally occur and may contribute to the pathogenesis of human enterovirus-induced dilated cardiomyopathy.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Satellite Stem Cells and Muscular Dystrophy
Cardiomyopathy V: Interprofessional Care

